Elosulfase alfa ERT associated with long-term endurance improvements in Morquio A.
Improvements over 2 years differed from the decline seen in untreated subjects.
Benefits were sustained regardless of baseline endurance, walking aid use, and age.
Long-term treatment also caused a sustained reduction in urine keratan sulfate.
No new or unexpected safety signals were identified with long-term ERT.